Citadel Advisors’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$997K Buy
18,400
+3,000
+19% +$197K ﹤0.01% 7659
2025
Q4
$946K Sell
15,400
-8,900
-37% -$575K ﹤0.01% 7515
2025
Q3
$1.78M Buy
24,300
+14,800
+156% +$1.17M ﹤0.01% 6321
2025
Q2
$707K Sell
9,500
-4,800
-34% -$336K ﹤0.01% 7816
2025
Q1
$1.07M Buy
14,300
+1,300
+10% +$121K ﹤0.01% 6810
2024
Q4
$1.33M Sell
13,000
-9,300
-42% -$1.07M ﹤0.01% 6461
2024
Q3
$2.35M Buy
22,300
+5,900
+36% +$603K ﹤0.01% 5225
2024
Q2
$1.53M Buy
16,400
+8,300
+102% +$880K ﹤0.01% 5815
2024
Q1
$1.05M Sell
8,100
-27,800
-77% -$3.27M ﹤0.01% 6810
2023
Q4
$4.07M Buy
35,900
+13,100
+57% +$1.14M ﹤0.01% 4098
2023
Q3
$1.87M Buy
22,800
+11,700
+105% +$1.03M ﹤0.01% 5334
2023
Q2
$1.04M Sell
11,100
-6,000
-35% -$480K ﹤0.01% 6376
2023
Q1
$1.16M Sell
17,100
-11,300
-40% -$914K ﹤0.01% 6451
2022
Q4
$2.02M Buy
28,400
+2,900
+11% +$198K ﹤0.01% 5465
2022
Q3
$1.58M Sell
25,500
-4,300
-14% -$310K ﹤0.01% 6041
2022
Q2
$1.99M Sell
29,800
-68,100
-70% -$5.12M ﹤0.01% 5555
2022
Q1
$7.04M Buy
97,900
+58,800
+150% +$4.82M ﹤0.01% 3541
2021
Q4
$3.74M Sell
39,100
-91,200
-70% -$6.18M ﹤0.01% 4883
2021
Q3
$6.37M Sell
130,300
-86,800
-40% -$4.36M ﹤0.01% 3854
2021
Q2
$10.9M Buy
217,100
+197,200
+991% +$9.7M ﹤0.01% 2951
2021
Q1
$780K Buy
19,900
+9,100
+84% +$354K ﹤0.01% 8699
2020
Q4
$316K Sell
10,800
-4,300
-28% -$110K ﹤0.01% 8981
2020
Q3
$325K Buy
+15,100
New +$244K ﹤0.01% 7995
2019
Q4
Sell
-10,500
Closed -$339K 9138
2019
Q3
$339K Buy
+10,500
New +$265K ﹤0.01% 7379
2019
Q2
Sell
-8,600
Closed -$229K 9192
2019
Q1
$229K Buy
+8,600
New +$244K ﹤0.01% 8017
2018
Q4
Sell
-7,800
Closed -$246K 9124
2018
Q3
$246K Sell
7,800
-1,400
-15% -$50.5K ﹤0.01% 7899
2018
Q2
$345K Buy
+9,200
New +$359K ﹤0.01% 6972

Other funds holding BXC

Citadel Advisors's BXC Position: Q1 2026 in Review

Citadel Advisors increased its BlueLinx (BXC) stake by 54% in Q1 2026, buying an estimated $629K and bringing the position to 27,395 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #6734.

Citadel Advisors first reported a position in BXC in Q4 2013 and has held it in 30 quarters since. The position peaked at $8.18M in Q4 2023. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.

  • Citadel Advisors held 27,395 shares of BlueLinx worth $1.48M as of Q1 2026.
  • Citadel Advisors bought 9,580 BlueLinx shares in Q1 2026, an estimated $629K.
  • BlueLinx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6734 holding.
  • Citadel Advisors first reported a position in BlueLinx in Q4 2013 and has held it in 30 quarters since.
  • Citadel Advisors's BlueLinx position peaked at $8.18M in Q4 2023.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.